TrialInternational journal of clinical practice2021

Intralesional low-dose methylprednisolone for the treatment of active phase Peyronie's disease: A single-centre, preliminary prospective non-randomised study.

Iyimser Ure et al.PubMed ↗Publisher ↗

No numbers read from the abstract.